主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 领航集团有限公司 | 是 | 19815.56万 | 9.74% | 不变 | 不变 | -- |
| 2 | 贝莱德集团公司 | 是 | 16809.82万 | 8.26% | 不变 | 不变 | -- |
| 3 | Sandra Leung | 否 | 46.54万 | 0.02% |
|
|
0.0229% |
| 4 | David V. Elkins | 否 | 22.36万 | 0.01% |
|
|
0.0110% |
| 5 | Julia A. Haller | 否 | 12.93万 | 0.0064% |
|
|
0.0064% |
| 6 | Christopher Boerner | 否 | 12.54万 | 0.0062% |
|
|
0.0062% |
| 7 | Theodore R. Samuels | 否 | 9.24万 | 0.0045% |
|
|
0.0045% |
| 8 | Samit Hirawat | 否 | 7.93万 | 0.0039% |
|
|
0.0039% |
| 9 | Peter J. Arduini | 否 | 6.09万 | 0.0030% |
|
|
0.0030% |
| 10 | Karen H. Vousden | 否 | 3.52万 | 0.0017% |
|
|
0.0017% |
| 11 | Phyllis R. Yale | 否 | 3.47万 | 0.0017% |
|
|
0.0017% |
| 12 | Derica W. Rice | 否 | 3.07万 | 0.0015% |
|
|
0.0015% |
| 13 | Paula A. Price | 否 | 2.04万 | 0.0010% |
|
|
0.0010% |
| 14 | Manuel Hidalgo Medina | 否 | 1.78万 | 0.0009% |
|
|
0.0009% |
| 15 | Karin Shanahan | 否 | 1.51万 | 0.0007% | 新增 | 新增 | 0.0007% |
| 16 | Deepak L. Bhatt | 否 | 1.45万 | 0.0007% |
|
|
0.0007% |
| 17 | Michael R. McMullen | 否 | 0.78万 | 0.0004% | 新增 | 新增 | 0.0004% |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-11-01 | Shanahan Karin |
|
2.01 | 0.00 | 是 | EVP, Chief Supply Chain & Ops |
| 2025-11-01 | Shanahan Karin |
|
1.69 | 46.07 | 是 | EVP, Chief Supply Chain & Ops |
| 2025-11-01 | Meyers Gregory Scott |
|
2.24 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-11-01 | Meyers Gregory Scott |
|
1.97 | 46.07 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-11-01 | BOERNER CHRISTOPHER S. |
|
0.30 | 0.00 | 是 | Chief Executive Officer |
| 2025-11-01 | BOERNER CHRISTOPHER S. |
|
0.24 | 0.00 | 是 | Chief Executive Officer |
| 2025-11-01 | BOERNER CHRISTOPHER S. |
|
0.12 | 46.07 | 是 | Chief Executive Officer |
| 2025-10-02 | Gallman Cari |
|
1.34 | 0.00 | 是 | EVP, General Counsel |
| 2025-10-02 | Gallman Cari |
|
1.11 | 45.73 | 是 | EVP, General Counsel |
| 2025-09-02 | Elkins David V |
|
16.74 | 47.33 | 是 | EVP, Chief Financial Officer |
| 2025-09-01 | Short Bartie Wendy |
|
0.63 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-09-01 | Short Bartie Wendy |
|
0.57 | 47.18 | 是 | EVP, Corporate Affairs |
| 2025-08-02 | Short Bartie Wendy |
|
0.54 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-08-02 | Short Bartie Wendy |
|
0.51 | 44.23 | 是 | EVP, Corporate Affairs |
| 2025-06-13 | BOERNER CHRISTOPHER S. |
|
-- | 0.00 | 是 | Chief Executive Officer |
| 2025-06-03 | BOERNER CHRISTOPHER S. |
|
6.27 | 0.00 | 是 | Chief Executive Officer |
| 2025-06-03 | Short Bartie Wendy |
|
0.80 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-06-03 | Short Bartie Wendy |
|
0.47 | 48.09 | 是 | EVP, Corporate Affairs |
| 2025-04-25 | Hirawat Samit |
|
8.35 | 47.58 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-04-01 | Shanahan Karin |
|
1.55 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-04-01 | Shanahan Karin |
|
1.38 | 59.55 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.16 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.11 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
10.78 | 63.11 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.44 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.33 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.05 | 63.11 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.72 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.61 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
11.32 | 63.11 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
15.29 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
13.83 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-10 | BOERNER CHRISTOPHER S. |
|
12.54 | 63.11 | 是 | Chief Executive Officer |
| 2025-03-10 | Gallman Cari |
|
0.96 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.83 | 63.11 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Elkins David V |
|
20.30 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Gallman Cari |
|
0.54 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Elkins David V |
|
20.67 | 63.11 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
22.34 | 63.11 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
25.26 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
23.57 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Gallman Cari |
|
0.52 | 63.11 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.61 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.60 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.57 | 63.11 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.66 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.64 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
0.62 | 63.11 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Gallman Cari |
|
1.16 | 0.00 | 是 | EVP, Corporate Affairs |
| 2025-03-10 | Elkins David V |
|
20.25 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
19.93 | 63.11 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
20.69 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
20.56 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
20.29 | 63.11 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
21.08 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Elkins David V |
|
20.95 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2025-03-10 | Hirawat Samit |
|
6.88 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
6.85 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
6.62 | 63.11 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
7.09 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
7.01 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
6.81 | 63.11 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
7.39 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
7.29 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
7.04 | 63.11 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
9.90 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
8.85 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Hirawat Samit |
|
7.93 | 63.11 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-03-10 | Holzer Phil M |
|
1.61 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.50 | 63.11 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.25 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.22 | 63.11 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.30 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.28 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.26 | 63.11 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.34 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.32 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.30 | 63.11 | 是 | SVP and Controller |
| 2025-03-10 | Holzer Phil M |
|
1.79 | 0.00 | 是 | SVP and Controller |
| 2025-03-10 | LEUNG SANDRA |
|
35.32 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.28 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.00 | 63.11 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.54 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.45 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.22 | 63.11 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.76 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.67 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
35.44 | 63.11 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
38.65 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
37.47 | 0.00 | 是 | EVP, General Counsel |
| 2025-03-10 | LEUNG SANDRA |
|
36.43 | 63.11 | 是 | EVP, General Counsel |
| 2025-03-10 | Shanahan Karin |
|
0.77 | 63.11 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
2.23 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
1.69 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
0.78 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
0.74 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
0.63 | 63.11 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
0.96 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
0.91 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Shanahan Karin |
|
1.22 | 63.11 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2025-03-10 | Lenkowsky Adam |
|
0.86 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.84 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.75 | 63.11 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.93 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.90 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.83 | 63.11 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
1.03 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.99 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
0.91 | 63.11 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
2.00 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
1.60 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Lenkowsky Adam |
|
1.24 | 63.11 | 是 | EVP, Chief Commercial Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.31 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.28 | 63.11 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.36 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.35 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.33 | 63.11 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.41 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.39 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.37 | 63.11 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.85 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.68 | 0.00 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Poole Ahn Amanda |
|
0.52 | 63.11 | 是 | EVP, Chief People Officer |
| 2025-03-10 | Hoch Lynelle |
|
0.23 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.20 | 63.11 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.29 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.27 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.24 | 63.11 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.35 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.33 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.29 | 63.11 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.79 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.61 | 0.00 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Hoch Lynelle |
|
0.47 | 63.11 | 是 | President, Cell Therapy Org. |
| 2025-03-10 | Meyers Gregory Scott |
|
0.98 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
0.93 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
0.83 | 63.11 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
1.16 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
1.11 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
0.99 | 63.11 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
2.69 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
2.07 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Meyers Gregory Scott |
|
1.61 | 63.11 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-03-10 | Plenge Robert M |
|
1.25 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.19 | 63.11 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.30 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.28 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.24 | 63.11 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.48 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.44 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.35 | 63.11 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
2.01 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.77 | 0.00 | 是 | EVP, Chief Research Officer |
| 2025-03-10 | Plenge Robert M |
|
1.58 | 63.11 | 是 | EVP, Chief Research Officer |
| 2025-03-01 | Hickey Benjamin |
|
1.04 | 0.00 | 是 | President, RayzeBio Org. |
| 2025-03-01 | Hickey Benjamin |
|
0.88 | 59.62 | 是 | President, RayzeBio Org. |
| 2025-02-20 | BOERNER CHRISTOPHER S. |
|
10.46 | 55.05 | 是 | Chief Executive Officer |
| 2025-02-14 | Hirawat Samit |
|
6.39 | 54.84 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2025-02-01 | Hickey Benjamin |
|
1.09 | 0.00 | 是 | President, RayzeBio Org. |
| 2025-02-01 | Hickey Benjamin |
|
0.71 | 58.95 | 是 | President, RayzeBio Org. |
| 2025-02-01 | Meyers Gregory Scott |
|
0.78 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2025-02-01 | Meyers Gregory Scott |
|
0.70 | 58.95 | 是 | EVP, Chief Digital & Tech Off. |
| 2024-11-04 | Holzer Phil M |
|
1.18 | 55.62 | 是 | SVP and Controller |
| 2024-11-01 | Hirawat Samit |
|
6.21 | 54.68 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-11-01 | BOERNER CHRISTOPHER S. |
|
10.42 | 0.00 | 是 | Chief Executive Officer |
| 2024-11-01 | BOERNER CHRISTOPHER S. |
|
10.26 | 54.32 | 是 | Chief Executive Officer |
| 2024-10-02 | Gallman Cari |
|
0.67 | 0.00 | 是 | EVP, Corporate Affairs |
| 2024-10-02 | Gallman Cari |
|
0.50 | 53.76 | 是 | EVP, Corporate Affairs |
| 2024-08-01 | Gallman Cari |
|
0.25 | 0.00 | 是 | EVP, Corporate Affairs |
| 2024-08-01 | Gallman Cari |
|
0.21 | 48.17 | 是 | EVP, Corporate Affairs |
| 2024-04-01 | Shanahan Karin |
|
0.53 | 52.99 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2024-04-01 | Shanahan Karin |
|
0.65 | 0.00 | 是 | EVP, Glob. Prod. Dev. & Supply |
| 2024-03-10 | Caforio Giovanni |
|
39.09 | 0.00 | 是 | Executive Chair of the Board |
| 2024-03-10 | Elkins David V |
|
17.66 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
17.54 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
17.30 | 53.79 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
18.11 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
17.97 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
17.69 | 53.79 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
22.51 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
20.83 | 0.00 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Elkins David V |
|
19.50 | 53.79 | 是 | EVP, Chief Financial Officer |
| 2024-03-10 | Caforio Giovanni |
|
38.72 | 0.00 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
37.71 | 53.79 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
40.09 | 0.00 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
39.68 | 0.00 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
38.68 | 53.79 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
52.97 | 0.00 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
47.99 | 0.00 | 是 | Executive Chair of the Board |
| 2024-03-10 | Caforio Giovanni |
|
43.23 | 53.79 | 是 | Executive Chair of the Board |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
8.84 | 0.00 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
8.75 | 0.00 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
8.50 | 53.79 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
9.20 | 0.00 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
9.08 | 0.00 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
8.79 | 53.79 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
12.98 | 0.00 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
11.52 | 0.00 | 是 | Chief Executive Officer |
| 2024-03-10 | BOERNER CHRISTOPHER S. |
|
10.12 | 53.79 | 是 | Chief Executive Officer |
| 2024-03-10 | Gallman Cari |
|
0.14 | 53.79 | 是 | EVP, Corporate Affairs |
| 2024-03-10 | Gallman Cari |
|
0.05 | 0.00 | 是 | EVP, Corporate Affairs |
| 2024-03-10 | Gallman Cari |
|
0.27 | 0.00 | 是 | EVP, Corporate Affairs |
| 2024-03-10 | Gallman Cari |
|
0.07 | 0.00 | 是 | EVP, Corporate Affairs |
| 2024-03-10 | Gallman Cari |
|
0.19 | 0.00 | 是 | EVP, Corporate Affairs |
| 2024-03-10 | Gallman Cari |
|
0.06 | 53.79 | 是 | EVP, Corporate Affairs |
| 2024-03-10 | Hoch Lynelle |
|
0.05 | 0.00 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Hoch Lynelle |
|
0.03 | 53.79 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Hoch Lynelle |
|
0.08 | 0.00 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Hoch Lynelle |
|
0.05 | 53.79 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Hoch Lynelle |
|
0.38 | 0.00 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Hoch Lynelle |
|
0.26 | 0.00 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Hoch Lynelle |
|
0.17 | 53.79 | 是 | President, Cell Therapy Org. |
| 2024-03-10 | Holzer Phil M |
|
1.06 | 0.00 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.03 | 53.79 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.10 | 0.00 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.09 | 0.00 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.07 | 53.79 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.49 | 0.00 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.35 | 0.00 | 是 | SVP and Controller |
| 2024-03-10 | Holzer Phil M |
|
1.25 | 53.79 | 是 | SVP and Controller |
| 2024-03-10 | Hirawat Samit |
|
5.14 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
5.08 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
4.90 | 53.79 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
5.39 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
5.30 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
5.09 | 53.79 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
8.03 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
7.01 | 0.00 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Hirawat Samit |
|
6.03 | 53.79 | 是 | EVP,Chief Med.Offr.,Drug Dev. |
| 2024-03-10 | Poole Ahn Amanda |
|
0.06 | 0.00 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.03 | 53.79 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.10 | 0.00 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.09 | 0.00 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.07 | 53.79 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.48 | 0.00 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.34 | 0.00 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Poole Ahn Amanda |
|
0.24 | 53.79 | 是 | EVP, Chief Human Resources |
| 2024-03-10 | Plenge Robert M |
|
1.28 | 0.00 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
1.13 | 53.79 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
0.79 | 0.00 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
0.78 | 0.00 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
0.75 | 53.79 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
0.87 | 0.00 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
0.85 | 0.00 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
0.82 | 53.79 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | Plenge Robert M |
|
1.52 | 0.00 | 是 | EVP, Chief Research Officer |
| 2024-03-10 | LEUNG SANDRA |
|
33.72 | 0.00 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
33.63 | 0.00 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
33.38 | 53.79 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
33.97 | 0.00 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
33.86 | 0.00 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
33.62 | 53.79 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
37.13 | 0.00 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
35.91 | 0.00 | 是 | EVP, General Counsel |
| 2024-03-10 | LEUNG SANDRA |
|
34.74 | 53.79 | 是 | EVP, General Counsel |
| 2024-03-10 | Lenkowsky Adam |
|
0.22 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.67 | 53.79 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.20 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.14 | 53.79 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.33 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.30 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.24 | 53.79 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
1.39 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2024-03-10 | Lenkowsky Adam |
|
0.99 | 0.00 | 是 | EVP, Chief Commercial Officer |
| 2024-02-01 | Meyers Gregory Scott |
|
0.60 | 0.00 | 是 | EVP, Chief Digital & Tech Off. |
| 2024-02-01 | Meyers Gregory Scott |
|
0.53 | 48.67 | 是 | EVP, Chief Digital & Tech Off. |